Condition
LDL-Cholesterol
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (2)
Trial Status
Not Yet Recruiting2
Completed1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06504043Phase 1Enrolling By Invitation
A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants
NCT06626126Not ApplicableNot Yet Recruiting
Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention
NCT05587621Not ApplicableNot Yet Recruiting
Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)
NCT04029818Phase 1Completed
Evaluation of a Probiotic on LDL-cholesterol Levels
Showing all 4 trials